IOWA SPECIALTY HOSPITAL - BELMOND — History
CCN 161301 | 3-year financial timeline | COVID resilience: 46/100
🛡️ Public data only — no PHI permitted on this instance.
$44M
Latest Revenue (FY2022)
+7.9%
Revenue CAGR (3yr)
-9.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $38M | $44M | $44M | +0.7% | +7.9% |
| Operating Expenses | $38M | $43M | $48M | +11.6% | +12.4% |
| Operating Margin | -0.4% | 1.7% | -9.0% | -619.4% | +0.0% |
| Net Income | $-0M | $1M | $-4M | -622.8% | +0.0% |
| Licensed Beds | 22 | 22 | 22 | +0.0% | +0.0% |
| Total Patient Days | 1,590 | 1,578 | 1,229 | -22.1% | -12.1% |
| Medicare Day % | 59% | 46% | 52% | +13.7% | -6.0% |
| Medicaid Day % | 0% | 0% | 0% | -78.6% | -57.0% |
COVID Impact & Recovery
Resilience Score: 46/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +16.4% ($38M → $44M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.9%
This Hospital
+7.6%
State Avg
Latest Margin
-9.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $48M | -13.2% |
| FY2024 (proj) | $51M | -17.5% |
| FY2025 (proj) | $54M | -21.8% |